UofL Department of Surgery Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

UofL Department of Surgery Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

University of Louisville Department of Surgery recently announced enrollment of the first patient in AngioDynamics’ NanoKnife® Irreversible Electroporation (IRE) "Data IRECancer Treatment” clinical study (DIRECT).

Read more about the DIRECT Study.